Alpha Teknova, Inc.
TKNO
Positions held
Your positionsTKNO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $453.13M | Enterprise value | $463.10M | Trailing P/E | — | Forward P/E | -44.42 |
| PEG | — | Price / book | 7.24 | Beta | 0.86 | Dividend yield | 0.00% |
| Revenue growth | 18.5% | Earnings growth | — | Gross margin | 34.6% | Operating margin | -23.7% |
| Profit margin | -38.4% | ROE | -24.2% | ROA | -9.3% | Debt / equity | 0.44 |
| Current ratio | 4.49 | Free cash flow | -$735,250 | Analyst recommendation | strong_buy | Mean target | $9.00 |
| 52w high | $9.48 | 52w low | $1.91 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $12.2M | $11.1M | $10.0M | $10.5M | $10.3M | — |
| Op margin | -23.7% | -38.8% | -46.2% | -38.4% | -32.9% | — |
| Net income | -$3.2M | -$4.6M | -$4.8M | -$4.3M | -$3.6M | — |
| Gross margin | 40.1% | 34.2% | 32.5% | 30.7% | 38.7% | — |
| Gross profit | $4.9M | $3.8M | $3.2M | $3.2M | $4.0M | — |
| Operating income | -$2.9M | -$4.3M | -$4.6M | -$4.0M | -$3.4M | — |
- Revenue +10% vs prior quarter ($12M vs $11M).
- Gross margin 40.1% (was 34.2% prior quarter).
- Operating margin expanded to -23.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $40.5M | $37.7M | $36.7M | $41.4M | — |
| Op margin | -41.9% | -69.3% | -85.0% | -69.7% | — |
| Net income | -$17.3M | -$26.7M | -$36.8M | -$47.5M | — |
| Gross margin | 33.2% | 19.2% | 28.1% | 42.2% | — |
| Gross profit | $13.4M | $7.2M | $10.3M | $17.5M | — |
| Operating income | -$17.0M | -$26.1M | -$31.2M | -$28.9M | — |
Headlines — positive tone
• [OK · fundamentals] All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy
• [OK · fundamentals] Alpha Teknova Inc (TKNO) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised Guidance ...
News
2026-10-02 · Alpha Teknova, Pluristyx Announce Preparation of PluriFreeze Drug Master File for US FDA Submission
2026-10-02 · Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
2026-10-01 · All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy
2026-09-22 · Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?
2026-09-17 · Jefferies & Co. Initiates Alpha Teknova With Buy Rating, $9 Price Target
2026-09-16 · Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
2026-08-20 · Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference
2026-08-19 · Alpha Teknova (TKNO) is a Great Momentum Stock: Should You Buy?
2026-08-18 · Sidoti Events, LLC's August Micro-Cap Virtual Conference
2026-08-11 · BTIG Upgrades Alpha Teknova to Buy From Neutral, Price Target is $8
2026-08-10 · Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade
2026-08-07 · Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand
Price (daily)
Full chart · RSI · MACD · patterns